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Jason Buehler, Kelly Lager, Amy Vincent, Cathy Miller,
Eileen Thacker, Bruce Janke1

Abstract. A potential mechanism by which highly pathogenic avian Influenza A virus subtype H5N1 could more readily
infect human beings is through the infection of and adaptation in pigs. To detect the occurrence of such infection, monitoring
of pig populations through serological screening would be highly desirable. In the current study, hemagglutination inhibition
assays were able to detect antibodies against H5N1 developed in pigs, but because of antigenic variation between clades,
the use of multiple virus strains were required. Whole recombinant virus and recombinant hemagglutinin antigen enzymelinked immunosorbent assays (ELISAs) were generated that could detect antibody against multiple H5N1 strains, but which
also detected antibody against endemic swine influenza viruses. A recombinant hemagglutinin antigen-based ELISA was as
effective as the whole virus antigen ELISAs in detecting antibody against the H5N1 virus strains used and eliminated nearly
all of the cross-reactivity with non-H5N1 virus antibody. The current study also highlighted the difficulty in establishing a
decision (cutoff) value that would effectively counterbalance nonspecific reactivity against sensitivity. The results provide
important information and considerations for the development of serological screening assays for highly pathogenic avian
H5N1 viruses.
Key words: Enzyme-linked immunosorbent assay; highly pathogenic avian Influenza A virus subtype H5N1; swine.
In 1997, a severe influenza-like illness was described in
human patients in several countries in Southeast Asia. Diagnostic testing determined that they had been infected with a
highly pathogenic avian Influenza A virus (HPAI) from the
H5N1 subtype.2,9,11 Infection of human beings by avian
influenza virus is uncommon, at least in part because avian
influenza viruses prefer α-2,3 sialic acid glycoprotein receptors. The relatively few α-2,3 viral receptors in the upper
respiratory tract of human beings may reduce susceptibility
to infection by airborne avian virus and decrease the likelihood of transmission to a human host.10 Nonetheless, direct
interspecies transmission of avian influenza to human beings
is possible and is postulated to have been responsible for the
1918 influenza pandemic.10
Beyond the high mortality induced in poultry, the greatest
concern with HPAI is the possibility of the virus adapting
and establishing itself within the human population either
through regular interspecies infection and horizontal transmission within the human population or through adaptation
in an intermediate host, such as the pig. Evidence suggests
the pig can serve as a “mixing vessel” supporting both human
and avian influenza virus replication, attributed to the presence of both α-2,6 (human-like) and α-2,3 (avian-like) sialic
acid receptors in the upper respiratory tract.3 In contrast to

human beings who in severe cases may require medical
attention after infection with HPAI H5N1, pigs are only
mildly affected by experimental or natural infection, suggesting the clinical impact of the virus on swine is minimal.1,6,7 The lack of clinical disease could result in
underreporting of HPAI H5N1 infection in pigs, allowing the
virus to persist in a small number of pigs within a population
and thus potentially facilitating adaptation. An HPAI H5N1
virus has been isolated from swine in Indonesia that expressed
a preference for the human-like α-2,6 sialic acid receptor
suggesting that viral adaptation had occurred.7 Because of
the potential risk that HPAI H5N1 infection of pigs could
pose to human health, as well as the potential negative
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economic impact on the swine industry itself, development
of screening tests that can identify H5N1 HPAI infection in
pigs would be valuable tools in preventing establishment of
this virus in swine populations.8 A serologic assay would be
a good adjunct to polymerase chain reaction (PCR)–based
tests for virus as antibody will circulate in serum for a longer
duration than virus will be shed in nasal secretions.
To be available for use under biosafety level (BSL) 2 conditions at which veterinary diagnostic laboratories operate,
H5N1 viruses in the assay would need to be attenuated. Three
recombinant H5N1 (rH5N1) viruses (A/Vietnam/1203/04
[rVN04], A/Whooper Swan/Mongolia/244/05 [rWS05], and
A/Japanese White Eye/Hong Kong/1038/06 [rJWE06]f) were
created using reverse genetics as previously described,3 to
attenuate the viruses for use in a BSL2+ environment.a
Briefly, the viruses encode the hemagglutinin (HA) and neuraminidase genes from 1 of the H5N1 isolates as well as the
remaining 6 genes from A/Puerto Rico/8/34 (PR8). The
viruses were grown in either embryonated chicken eggs or
Madin–Darby canine kidney cells.b The HA units (HAU)/ml
were determined for each virus using 2-fold serial dilutions of
the virus preparations in phosphate buffered saline (PBS) and
incubating with 1% turkey red blood cells (RBCs) in PBS.
The virus solutions were placed in 100-mm dishes and then
ultraviolet (UV)-inactivated for 3 min using a UV crosslinker.c
Ultraviolet inactivation of the virus was confirmed to be replication deficient using an immunocytochemistry TCID50
assay, as previously described.4 Virus suspensions were
diluted with PBS to a concentration of 128 HAU/ml, with the
exception of the initial preparation of rWS05 that had a concentration of 96 HAU/ml.
To obtain H5N1-specific antiserum for use in the development of immunological assays for screening of H5N1
antibodies, 5-week-old pigs were vaccinated with each of the
3 recombinant viruses. The vaccine preparations also contained a final concentration of 20% v/v adjuvant.d Pigs were
vaccinated and booster doses administered at 14 and 33 days
post initial vaccination (DPV). Serum samples were collected prior to vaccination and at 8, 14, 22, 33, and 40 DPV.
All animal work was performed in compliance with the
National Animal Disease Center Institutional Animal Care
and Use Committee guidelines.
Antibody titers for the serum samples were determined
using hemagglutination inhibition (HI) assay. Serum samples were treated with receptor destroying enzyme (RDEe;
100 µl of serum to 300 µl of RDE solution) and incubated
overnight at 37°C. After RDE treatment, serum was brought
to a final 1:10 dilution by the addition of physiological saline
(0.85% w/v NaCl solution) and serially diluted into 96-well
U-bottom plates using 2-fold serial dilutions ranging from
1:10 to 1:2,560. An equivalent volume of virus at 8 HAU/ml
concentration was added to each well and incubated at room
temperature for 1 hr. Another volume of 1% turkey RBCs in
PBS was added, incubated for another hour, and HI titers
were determined as the reciprocal of the highest dilution

Table 1. Heterospecific geometric mean hemagglutination
inhibition assay titers comparing antibody titers against the
recombinant (r)H5N1 viruses at 40 days postvaccination.*
Virus
Pig
VN-1
VN-2
WS-1
WS-2
JWE-1
JWE-2

rVN04

rWS05

rJWE06

508
508
320
160
40
40

80
40
1,280
806
80
80

320
320
1,280
640
640
905

* Boldface indicates homologous hemagglutination inhibition assay titers.

completely inhibiting agglutination. Reported HI titers are
the geometric mean of 3 individual HI assay replicates. At 8
DPV, rVN04- and rJWE06-vaccinated pigs had HI titers of
80, while rWS05 pigs had HI titers of 160. By 40 DPV, geometric mean HI titers increased to 508 for both rVN04vaccinated pigs, 1208 and 806 for rWS05-vaccinated pigs,
and 640 for rJWE06-vaccinated pigs.
Additionally, HI assays were performed using the serum
samples collected at 40 DPV to determine the relative HI antibody cross-reactivity between the rH5N1 viruses (Table 1).
The heterospecific HI titers differed substantially depending
on the viral strain used for antibody detection. The HI assays
using rVN04 or rWS05 viruses against heterologous serum
samples differed by 4- to 16-fold from HI titers measured
against homologous virus. However, when the rJWE06 virus
was used for detection of antibody in serum from pigs vaccinated with rVN04 and rWS05, the HI titers of the heterologous serum samples were similar to those measured in
homologous serum (within a 2-fold difference). These results
indicate that, similar to HI tests against endemic swine
viruses, the ability to detect antibody against H5N1 in swine
serum using HI assays is dependent on the viral strains used
for detection and would likely require use of multiple strains
in order to assure detection of all virus clades.5
To determine if antigenic variation among HPAI H5N1
viruses would similarly interfere with enzyme-linked immunosorbent assay (ELISA) format serologic testing, single
antigen indirect ELISAs were generated using each rH5N1
virus. Additionally, to determine if potential cross-reactivity
issues were characteristic of the hemagglutinins (as opposed
to other virus proteins), a commercially available recombinant HA protein (rHA) from A/Vietnam/1203/04k also was
used as an antigen. Components for the ELISAs were optimized using a checkerboard format to compare concentration of antigens (2–256 HAU/ml of each of the rH5N1
viruses or 0.03–4 µg/ml recombinant HA protein from A/
Vietnam/1203/05f) in different combinations with homologous serum sample dilutions (1:10–1:20,480). Additional
assays were performed to optimize the conjugate antibody
dilution (1:500–1:64,000). Using the optimized conditions

ELISA detection of H5N1 antibody in swine
Table 2. Optimized enzyme-linked immunosorbent assay
(ELISA) protocol conditions determined from checkerboard
analysis for the whole virus and recombinant hemagglutinin
ELISA assays.*
rVN04
Sample dilution
Antigen concentration
Conjugate dilution

rWS05

1:160
1:160
64 HAU 64 HAU
1:500
1:500

rJWE06

rHA

1:320
1:80
256 HAU 4 µg/ml
1:500
1:500

* HAU = hemagglutinin units.

(Table 2), platesg were coated with 100 µl of diluted rH5N1
virus or rHA resuspended in PBS and incubated overnight at
37°C. Plates were washed 3 times using PBS with 0.05%
Tween 20 (PBST) and tapped onto paper towels between
washes to remove residual liquid. Serum samples were then
diluted with ELISA diluent (PBS with 0.5% gelatin, 0.15%
Tween 20, and 4% goat serum), and 100 µl of a diluted sample was added to a well and incubated at room temp for 1.5 hr.
After the plates were washed 3 times with PBST, 100 µl of
anti-swine HRPh diluted 1:500 in ELISA diluent was added
to each well and incubated for 1 hr at room temperature. The
plates were washed 3 times with PBST prior to the addition
of 100 µl of substrate (10 mg of o-phenylenediamine in 20
ml of 0.05 M phosphate citrate buffer, containing 0.03%
sodium perborate). The plates were incubated until color
development was complete (approximately 1 min) and
stopped with 1 N sulfuric acid. Using a plate reader,g sample
absorbance (optical density [OD]) was determined at a wavelength of 492 nm. The serum from the pigs vaccinated with
the attenuated H5N1 viruses were tested by the abovedescribed ELISAs.
Because nearly all conventional swine have antibody to
multiple endemic swine influenza viruses, cross-reactivity
by these antibodies in the H5N1 ELISAs would preclude
their use for surveillance. Serum from pigs infected in a previous study with influenza viruses (A/Swine/Wisconsin/
R33f/01 [H1N2], A/Swine/Iowa/40776/93 [H1N1], A/
Swine/Iowa/35233/99 [H1N1], A/Swine/Texas/4199-2/98
[H3N2], and A/Swine/Wisconsin/R7c/01 [H3N2]), 1 pig per
virus, were also tested.5 Homologous HI titers for the
endemic swine serum samples ranged from 160 to 1,280.
All 3 recombinant ELISAs were able to detect antibody,
both homologous and heterologous, in nearly all samples collected after 22 DPV but only inconsistently in serum samples
collected earlier. The VN04 ELISA was able to detect antibody in more of the earlier samples. The HI test was more
sensitive for all 3 recombinant viruses, detecting geometric
mean antibody titers of 80–160. However, all 3 ELISAs also
detected antibody in 8 of 10 of the non-H5 serum samples
(5 samples run in 2 replicates). The rHA ELISA detected antibody in nearly all samples from the recombinant H5–vaccinated
pigs collected after 22 DPV. However, antibody was detected
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Table 3. Specificity and sensitivity for each enzyme-linked
immunosorbent assay determined through receiver operating
characteristic analysis and calculation of cutoff values.
Assay
rVN04
rWS05
rJWE06
rHA

Cutoff *

Specificity (%)

Sensitivity (%)

1.357
0.930
0.647
0.503

100
100
100
100

48
37
38
60

* Only cutoff values with non-H5N1 sensitivity equaling zero
were considered (see Supplemental Tables 1–4 online at
http://jvdi.sagepub.com/supplemental).

by this test in only 2 of the replicate samples of non-H5 serum,
and the OD values were just above the cutoff value.
Data from 2 independent ELISA replicates were combined and analyzed using receiver operating characteristics
(ROC)i for determination of the cutoff values and calculation of the sensitivity and specificity for each assay (Table
3). For ROC analysis of these assays, all non-H5 serum
samples collected between 8 DPV and 40 DPV, regardless
of the virus used for vaccination, were considered positive.
To minimize the potential for false positive results (which
could pose serious economic difficulties for a herd under
test), cutoff values were selected for each assay that eliminated detection of non-H5N1 serum samples; at these cutoff
values, all 4 ELISAs had specificities of 100% (Table 3).
Based on these parameters, the rWS05 and rJWE06 ELISAs
appeared to have similarly low sensitivities of 37% and
38%, respectively. The rVN04 ELISA out-performed both
of the other whole virus assays with a sensitivity of 48%.
Analyzed in this manner, the results suggest that the majority of positive samples from rH5N1-vaccinated pigs were
undetected with this assay. This apparent lack of sensitivity
may have been artificially enhanced as a result of the decision threshold imposed by the relatively high cross-reactivity with the non-H5 antibodies. This cross-reactivity could
be expected since the recombinant viruses contain a PR8
influenza backbone ancestrally related to classical swine
influenza.
In contrast, the rHA antigen ELISA had a greater ability
to differentiate between anti-H5 and anti–non-H5 antibody.
By ROC analysis, at the cutoff value (the highest OD value
at which no non-H5 antibody was detected but at which
H5N1 specificity was 100%) the H5N1 sensitivity was 60%,
which is substantially higher than that of the whole recombinant virus assays. These results suggest rHA ELISAs may be
preferable to recombinant whole virus assays. Selecting a
lower cutoff value would result in an increase in sensitivity,
but would decrease the ability of the assay to differentiate
between endemic swine influenza H1 and H3 subtypes and
H5N1 serum samples.
Serological assays provide a number of benefits when
screening large populations for the prevalence of H5N1 influenza in pigs, especially the ability to detect the occurrence of
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infection for an extended period of time after active viral replication has ceased. As stated earlier, pigs may present with
subclinical symptoms and go unnoticed through the course of
infection, making acquisition of viral RNA for use in realtime RT-PCR assays difficult. This study utilized 3 different
serological assays and illustrated the hurdles encountered
when analyzing serum samples from potentially H5N1
infected pigs.
Results obtained in the current study indicate whole
recombinant H5N1 ELISAs prepared as described would
not be useful because of cross-reactivity with antibody
against endemic swine viruses, but that the rHA indirect
ELISA format may be more promising. In its current state,
the rHA ELISA would not be useful as a differential diagnostic tool, but could be useful as a surveillance tool.
Decreasing the cross-reactivity of the assay to non-H5N1
serum samples may increase the sensitivity, by allowing
lower cutoff values. Such assay conditions in which detection of non-H5N1 sera is minimized may have been
achieved by including non-H5N1 sera during concentration optimization procedures during development. Future
work is needed to further optimize the ELISA to increase
sensitivity and minimize the effects that heterosubtypic
antibodies have on specificity. Even if sensitivity of the
rHA ELISA could be improved through methodology
improvements, antigen variation among H5 hemagglutinins might require use of a multiplex of different rHAs.
The differences in cross-reactivity between H5 antigens
exhibited in both HI and the whole recombinant virus ELISAs in the present study would suggest that as another difficulty.
A number of the commercially available H5N1 ELISAs for avian species also use rHA antigen to coat the
plates, such as developed by Gentaur j and Green Spring.i
Comparison of the 4 ELISA assays described herein with
these commercially available H5N1-specific ELISAs may
have proven valuable in development efforts. The other
H5N1 ELISAs utilizing a similar platform appear to be
primarily developed for use with avian serum samples and
would require both modification and optimization of the
assay for use with swine serum samples. However, such
modification of a commercially available avian H5N1
ELISA kit may be a more cost efficient approach. In conclusion, this work lays the groundwork for the development of a serological assay for detecting antibodies
against H5N1 that could be standardized for diagnostic
use in pigs.
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